Previous Article | Next Article ![]()
Journal of Virology, December 1999, p. 10095-10103, Vol. 73, No. 12
Department of Molecular Biology,
Received 26 October 1998/Accepted 31 August 1999
Adenovirus (Ad) E4orf6/7, one of the early gene products of human
Ads, forms a stable complex with the cellular transcription factor E2F
to activate transcription from the Ad E2 promoter. E2F cDNAs have
growth-promoting and apoptosis-inducing activities when
overexpressed in cells. We cloned Ad5 E4orf6/7 cDNA in both simian
virus 40- and human cytomegalovirus-based expression vectors to examine
its transforming and apoptotic activities. The cloned E4orf6/7
collaborated with a retinoblastoma protein (RB)-nonbinding and
therefore E2F-nonreleasing mutant of Ad5 E1A (dl922/947) to morphologically transform primary rat cells, suggesting that E2F is an
important cellular protein functioning downstream of E1A for
transformation. In a G418 colony formation assay, E4orf6/7 was shown to
suppress growth of untransformed rat cells. Moreover, a recombinant Ad
expressing Ad5 E4orf6/7 induced apoptosis in rat cells when coinfected
with wild-type p53-expressing Ad. Mutational analysis of E4orf6/7
revealed that both of the domains required for growth inhibition
and transformation by E4orf6/7 lay in the C-terminal region, which is
essential for transactivation from the upstream sequence of an E2a
promoter containing E2F-binding sites. However, the smallest mutant of
E4orf6/7, encoding the C-terminal 59 amino acids, failed to complement
the RB-nonbinding dl922/947 mutant despite showing growth
inhibition and E2F transactivation activities. Thus, it is suggested
that a subregion of E4orf6/7 which is required for growth inhibition
and transformation in collaboration with dl922/947 overlaps
the transactivation domain of E4orf6/7.
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Induction of Transformation and p53-Dependent
Apoptosis by Adenovirus Type 5 E4orf6/7 cDNA
and
*
Corresponding author. Mailing address: Department
of Molecular Biology, Cancer Research Institute, Sapporo Medical
University School of Medicine, South 1, West 17, Chuo-ku, Sapporo
060, Japan. Phone: 81-11-611-2111. Fax: 81-11-618-3313. E-mail:
yamasita{at}sapmed.ac.jp.
Present address: Biotechnology Research Laboratories, Takara Shuzo
Co., Ltd., Noji, Kusatsu, Shiga 525, Japan.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|